OpenSAFELY
Reports

Vaccine Coverage

Description
Weekly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
22 Dec 2020
Last updated
10 Jan 2022
Links

OpenSAFELY COVID Vaccine coverage report

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our paper available here.

The full analytical methods behind the latest results in this report are available here.

Report last updated 10 Jan 2022

Vaccinations included up to 05 Jan 2022 inclusive

Contents:

Overview of Vaccination Figures to date

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home. ####
first dose as at 05 Jan 2022 second dose as at 05 Jan 2022 third dose as at 05 Jan 2022
Group
Total vaccinated in TPP 16,717,267 15,867,481 11,912,551
80+ 96.9% (1,055,572 of 1,089,634) 96.0% (1,045,667 of 1,089,634) 91.3% (994,539 of 1,089,634)
70-79 96.4% (2,019,059 of 2,095,366) 95.5% (2,000,117 of 2,095,366) 91.4% (1,915,095 of 2,095,366)
care home 97.0% (107,079 of 110,383) 93.5% (103,250 of 110,383) 85.1% (93,898 of 110,383)
shielding (aged 16-69) 91.9% (758,380 of 825,251) 89.2% (735,812 of 825,251) 72.9% (601,608 of 825,251)
65-69 94.0% (1,023,512 of 1,088,416) 92.7% (1,009,253 of 1,088,416) 87.0% (947,002 of 1,088,416)
LD (aged 16-64) 88.3% (75,292 of 85,253) 83.9% (71,554 of 85,253) 62.8% (53,578 of 85,253)
60-64 92.4% (1,208,725 of 1,307,600) 90.9% (1,188,201 of 1,307,600) 82.4% (1,076,866 of 1,307,600)
55-59 90.6% (1,393,161 of 1,537,634) 88.8% (1,365,175 of 1,537,634) 77.3% (1,188,530 of 1,537,634)
50-54 88.3% (1,397,438 of 1,582,154) 86.1% (1,362,718 of 1,582,154) 71.5% (1,130,549 of 1,582,154)
40-49 81.1% (2,426,641 of 2,991,716) 77.9% (2,329,075 of 2,991,716) 55.6% (1,663,109 of 2,991,716)
30-39 71.9% (2,435,440 of 3,385,319) 66.6% (2,255,918 of 3,385,319) 37.7% (1,274,833 of 3,385,319)
18-29 70.1% (2,461,459 of 3,511,522) 61.9% (2,173,612 of 3,511,522) 27.3% (958,146 of 3,511,522)
16-17 66.4% (355,502 of 535,304) 42.4% (227,136 of 535,304) 2.8% (14,798 of 535,304)

NB Patient counts are rounded to nearest 7

Second doses are at least 19 days after the first; third doses at least 8 weeks after the second;

All second and third/booster doses given in these timescales are counted whether or not they were 'due' according to the relevant dosing schedule at the time.

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all first doses): 50.2% (8,396,696)

Pfizer vaccines (% of all first doses): 47.0% (7,855,904)

Moderna vaccines (% of all first doses): 2.8% (466,214)

Second doses and dose combinations

Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report

Second doses (% of all vaccinated): 94.9% (15,867,481)

Second doses (% of Ox-AZ first doses): 98.6% (8,278,137)

Second doses (% of Pfizer first doses): 91.8% (7,212,205)

Second doses (% of Moderna first doses): 81.5% (379,995)


Note: mixed doses counts patients with first and second doses at least 19 days apart, excluding patients with two different brands recorded on the same day or recorded on a date prior to when the given brand was available in the UK

Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.5% (85204)

Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.1% (13741)

Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.1% (17626)

Summary Charts

Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.

*Latest overall cohort rate calculated as at latest date for vaccinations recorded across all TPP practices.

80+ population

COVID vaccinations among 80+ population

by Sex

COVID vaccinations among 80+ population

by Ethnicity (broad categories)

COVID vaccinations among 80+ population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 80+ population

by BMI